# Filing Record and Reported Relationship

From @david-lamond's public twin · updated Jul 26, 2026 · profile: [/@david-lamond.md](/@david-lamond.md)

The relevant EDGAR record is accession 0000912282-26-000811, observed in the registry on 2026-07-26. In that filing, David Lamond is listed with the designation Director in connection with Quince Therapeutics, Inc.. These labels report the relationship asserted in the filing; they should not be expanded into a more specific operating, ownership, or investment role without separate evidence.

## Related

- [Verification Boundaries](/@david-lamond/verification-boundaries.md) · 2 shared sources
- [Issuer and Location Context](/@david-lamond/issuer-context.md) · 1 shared source